US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4341755A
(en)
|
1980-07-15 |
1982-07-27 |
Immuno Nuclear Corporation |
Parathyroid radioimmunoassay
|
JPS58166633A
(ja)
|
1982-03-29 |
1983-10-01 |
Toshiba Corp |
有機溶媒電池用正極
|
JPS58166634A
(ja)
|
1982-03-29 |
1983-10-01 |
Toshiba Corp |
有機溶媒電池用正極
|
US4666697A
(en)
|
1982-12-08 |
1987-05-19 |
Nihon Medi-Physics Co., Ltd. |
Radioactive diagnostic agent
|
US4740461A
(en)
|
1983-12-27 |
1988-04-26 |
Genetics Institute, Inc. |
Vectors and methods for transformation of eucaryotic cells
|
JPS62170639A
(ja)
|
1986-01-22 |
1987-07-27 |
株式会社システムメンテナンス |
防蟻板の取付け工法
|
US4959455A
(en)
|
1986-07-14 |
1990-09-25 |
Genetics Institute, Inc. |
Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
|
US4912040A
(en)
|
1986-11-14 |
1990-03-27 |
Genetics Institute, Inc. |
Eucaryotic expression system
|
US5476996A
(en)
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
ATE356869T1
(de)
|
1990-01-12 |
2007-04-15 |
Amgen Fremont Inc |
Bildung von xenogenen antikörpern
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
ATE352612T1
(de)
|
1990-08-29 |
2007-02-15 |
Pharming Intellectual Pty Bv |
Homologe rekombination in säugetier-zellen
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
JP3005313B2
(ja)
|
1991-05-14 |
2000-01-31 |
三菱電機株式会社 |
エンジンの制御方法
|
WO1992022670A1
(en)
|
1991-06-12 |
1992-12-23 |
Genpharm International, Inc. |
Early detection of transgenic embryos
|
AU2235992A
(en)
|
1991-06-14 |
1993-01-12 |
Genpharm International, Inc. |
Transgenic immunodeficient non-human animals
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
EP0746609A4
(en)
|
1991-12-17 |
1997-12-17 |
Genpharm Int |
NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
|
EP0566135A1
(en)
|
1992-04-17 |
1993-10-20 |
Takeda Chemical Industries, Ltd. |
Transmucosal composition comprising a peptide and a cytidine derivative
|
NZ253943A
(en)
|
1992-06-18 |
1997-01-29 |
Genpharm Int |
Transfering polynucleotides into eukaryotic cells using co-lipofection complexes of a cationic lipid and the polynucleotide
|
WO1994002602A1
(en)
|
1992-07-24 |
1994-02-03 |
Cell Genesys, Inc. |
Generation of xenogeneic antibodies
|
US5981175A
(en)
|
1993-01-07 |
1999-11-09 |
Genpharm Internation, Inc. |
Methods for producing recombinant mammalian cells harboring a yeast artificial chromosome
|
AU6819494A
(en)
|
1993-04-26 |
1994-11-21 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5625825A
(en)
|
1993-10-21 |
1997-04-29 |
Lsi Logic Corporation |
Random number generating apparatus for an interface unit of a carrier sense with multiple access and collision detect (CSMA/CD) ethernet data network
|
DE4434551A1
(de)
|
1994-09-28 |
1996-04-04 |
Forssmann Wolf Georg Prof Dr D |
Peptide aus der Sequenz des hPTH (1-37)
|
US5643763A
(en)
|
1994-11-04 |
1997-07-01 |
Genpharm International, Inc. |
Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6428771B1
(en)
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US6706484B1
(en)
*
|
1995-08-18 |
2004-03-16 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
CA2230759C
(en)
|
1995-08-29 |
2012-02-21 |
Kirin Beer Kabushiki Kaisha |
Chimeric animal and method for producing the same
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
WO1998001417A1
(fr)
|
1996-07-08 |
1998-01-15 |
Kirin Beer Kabushiki Kaisha |
Composes actifs comme recepteurs du calcium
|
US7521531B2
(en)
|
1996-08-28 |
2009-04-21 |
Immunomedics, Inc. |
Methods for the purification of stable radioiodine conjugates
|
WO1998024893A2
(en)
|
1996-12-03 |
1998-06-11 |
Abgenix, Inc. |
TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
UA59384C2
(uk)
|
1996-12-20 |
2003-09-15 |
Пфайзер, Інк. |
Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
ES2263204T5
(es)
|
1997-04-15 |
2013-10-14 |
Daiichi Sankyo Company, Limited |
Nueva proteína y proceso para producir la misma
|
WO1999013864A2
(en)
|
1997-09-19 |
1999-03-25 |
Shire Laboratories, Inc. |
Solid solution beadlet
|
US6770623B1
(en)
|
1997-12-09 |
2004-08-03 |
Eli Lilly And Company |
Stabilized teriparatide solutions
|
EE200000546A
(et)
|
1998-03-16 |
2002-02-15 |
Inhale Therapeutic Systems, Inc. |
Aerosoolistatud toimeaine manustamissüsteem
|
US6902721B1
(en)
|
1998-07-10 |
2005-06-07 |
Osteoscreen, Inc. |
Inhibitors of proteasomal activity for stimulating bone growth
|
US6697669B2
(en)
|
1998-07-13 |
2004-02-24 |
Genetronics, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
US6696550B2
(en)
*
|
1998-07-23 |
2004-02-24 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
WO2000006184A1
(en)
|
1998-07-27 |
2000-02-10 |
Emisphere Technologies, Inc. |
Pulmonary delivery of active agents
|
AUPP494798A0
(en)
|
1998-07-29 |
1998-08-20 |
Pacific Biolink Pty Limited |
Protective protein formulation
|
US20040033950A1
(en)
|
2000-09-26 |
2004-02-19 |
Hock Janet M. |
Method of increasing bone toughness and stiffness and reducing fractures
|
US6720153B1
(en)
|
1998-09-04 |
2004-04-13 |
Aventis Pharmaceuticals Inc. |
Luciferase reporter bioassay of parathyroid hormone compounds
|
US6566073B1
(en)
|
1998-10-19 |
2003-05-20 |
Ariad Gene Therapeutics, Inc. |
Materials and methods involving conditional retention domains
|
FR2785284B1
(fr)
|
1998-11-02 |
2000-12-01 |
Galderma Res & Dev |
Analogues de la vitamine d
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
US6663870B2
(en)
|
1998-12-07 |
2003-12-16 |
Zymogenetics, Inc. |
Methods for promoting growth of bone using zvegf3
|
US20040029175A1
(en)
|
1998-12-21 |
2004-02-12 |
Comper Wayne D. |
Method for kidney disease detection
|
US6627228B1
(en)
|
1999-01-08 |
2003-09-30 |
Emisphere Technologies, Inc. |
Polymeric delivery agents and delivery agents compounds
|
US6689566B1
(en)
|
1999-01-14 |
2004-02-10 |
Scantibodies Laboratory, Inc. |
Methods, kits, and antibodies for detecting parathyroid hormone
|
US6713293B1
(en)
|
1999-02-08 |
2004-03-30 |
Friedrich Grummt |
Encapsulated cells containing an amplified expression vector as a drug delivery device
|
EP1163209A4
(en)
|
1999-02-26 |
2004-12-29 |
Emisphere Tech Inc |
COMPOUNDS AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE INGREDIENTS
|
US6518292B1
(en)
|
1999-03-12 |
2003-02-11 |
Bristol-Myers Squibb Co. |
Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
|
US6767928B1
(en)
|
1999-03-19 |
2004-07-27 |
The Regents Of The University Of Michigan |
Mineralization and biological modification of biomaterial surfaces
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
WO2001000654A2
(en)
|
1999-06-29 |
2001-01-04 |
Pharmaceutical Discovery Corporation |
Purification and stabilization of peptide and proteins in pharmaceutical agents
|
AU5708500A
(en)
*
|
1999-07-02 |
2001-01-22 |
Chugai Seiyaku Kabushiki Kaisha |
Remedies for diseases caused by pth or pthrp
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6693208B2
(en)
|
1999-12-16 |
2004-02-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
EP1113007A1
(en)
|
1999-12-24 |
2001-07-04 |
Pfizer Inc. |
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
|
US6649161B1
(en)
|
2000-02-22 |
2003-11-18 |
Allergan, Inc. |
Method for treating hypocalcemia
|
US20040037834A1
(en)
|
2000-04-20 |
2004-02-26 |
Woloski B. Michael R. |
Rhamm peptide conjugates
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
EP1283057B2
(en)
|
2000-04-28 |
2012-05-30 |
Chugai Seiyaku Kabushiki Kaisha |
Cell proliferation inhibitors
|
FR2809309B1
(fr)
|
2000-05-23 |
2004-06-11 |
Mainelab |
Microspheres a liberation prolongee pour administration injectable
|
US6812345B2
(en)
|
2000-06-15 |
2004-11-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
JP2004521857A
(ja)
|
2000-06-29 |
2004-07-22 |
エミスフェアー・テクノロジーズ・インク |
活性剤の送達のための化合物及び組成物
|
US20040047910A1
(en)
|
2000-07-07 |
2004-03-11 |
Christian Beckett |
Suppository and composition comprising at least one polyethylene glycol
|
AU2001277935B2
(en)
|
2000-07-26 |
2005-08-04 |
Merck & Co., Inc. |
Alpha v integrin receptor antagonists
|
SE516555C2
(sv)
|
2000-08-04 |
2002-01-29 |
Microdrug Ag |
Elektropulver
|
AU2001278742A1
(en)
|
2000-08-16 |
2002-02-25 |
Chugai Seiyaku Kabushiki Kaisha |
Agents for ameliorating symptoms caused by joint diseases
|
JP4707931B2
(ja)
|
2000-08-18 |
2011-06-22 |
エミスフェアー・テクノロジーズ・インク |
活性剤デリバリー用化合物および組成物
|
EP1317412A1
(en)
|
2000-08-18 |
2003-06-11 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
ES2258371B1
(es)
|
2000-08-31 |
2007-05-16 |
Dong Kook Pharmaceutical Co. Ltd. |
Levadura transformante productora de hormona paratiroidea humana y procedimiento para producir la hormona.
|
ATE396967T1
(de)
|
2000-09-06 |
2008-06-15 |
Emisphere Tech Inc |
(5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
|
US7186683B2
(en)
|
2000-09-18 |
2007-03-06 |
Sanos Bioscience A/S |
Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
EP1335661B1
(en)
|
2000-10-27 |
2009-05-06 |
Baxter Healthcare S.A. |
Production of microspheres
|
EP2316490A3
(en)
|
2000-10-31 |
2012-02-01 |
PR Pharmaceuticals, Inc. |
Methods and compositions for enhanced delivery of bioactive molecules
|
EP1344536A4
(en)
|
2000-11-24 |
2005-01-19 |
Chugai Pharmaceutical Co Ltd |
METHOD FOR REGULATING THE ACTIVITY OF EXPRESSION OF A GENETIC PRODUCT TRANSFERRED INTO A LIVING ORGANISM
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
US20020106331A1
(en)
|
2000-12-08 |
2002-08-08 |
Joan Rosell |
Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols
|
US7270968B2
(en)
|
2000-12-14 |
2007-09-18 |
The General Hospital Corporation |
PTH analogs for renal osteodystrophy and related uses
|
US20030225300A1
(en)
|
2001-04-19 |
2003-12-04 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
SG173211A1
(en)
|
2001-06-26 |
2011-08-29 |
Amgen Inc |
Antibodies to opgl
|
US20030073609A1
(en)
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
US20030082179A1
(en)
|
2001-07-03 |
2003-05-01 |
Hutchison James Scott |
Parathyroid hormone antibodies and related methods
|
US6645974B2
(en)
|
2001-07-31 |
2003-11-11 |
Merck & Co., Inc. |
Androgen receptor modulators and methods for use thereof
|
EP1414795A4
(en)
|
2001-07-31 |
2006-03-01 |
Bristol Myers Squibb Co |
BICYCLIC MODULATORS OF THE FUNCTION OF THE ANDROGEN RECEPTOR
|
US7504481B2
(en)
|
2001-08-02 |
2009-03-17 |
Bristol-Meyers Squibb Company |
TRP channel family member, LTRPC3 polypeptides
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US20040043003A1
(en)
|
2002-01-31 |
2004-03-04 |
Wei Chen |
Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
|
AU2003213647A1
(en)
|
2002-02-27 |
2003-09-09 |
Emory University |
Multimeric binding complexes
|
US7381730B2
(en)
|
2002-03-15 |
2008-06-03 |
Bristol-Myers Squibb Company |
3-arylquinazoline derivatives as selective estrogen receptor beta modulators
|
CA2479665C
(en)
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
WO2003083440A2
(en)
|
2002-03-29 |
2003-10-09 |
Genentech, Inc. |
Methods and compositions for detection and quantitation of nucleic acid analytes
|
US6696474B2
(en)
|
2002-04-03 |
2004-02-24 |
Warner Lambert Co. Llc. |
Antidiabetic agents
|
US6716842B2
(en)
|
2002-04-05 |
2004-04-06 |
Warner-Lambert Company, Llc |
Antidiabetic agents
|
US6992093B2
(en)
|
2002-05-02 |
2006-01-31 |
Los Angeles Biomedical Research Institute At Harbor Ucla Medical Center |
Method of inhibiting lipofibroblast to myofibroblast transdifferentiation
|
US20030220377A1
(en)
|
2002-05-08 |
2003-11-27 |
Richard Chesworth |
Indole compounds and their use as estrogen agonists/antagonists
|
TW200407324A
(en)
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
CA2487928A1
(en)
|
2002-05-31 |
2003-12-11 |
Mcgill University |
Pthrp-based prediction and diagnosis of bone disease
|
AU2003253621A1
(en)
|
2002-06-14 |
2003-12-31 |
Centocor, Inc. |
Modified "s" antibodies
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
US20040002770A1
(en)
|
2002-06-28 |
2004-01-01 |
King Richard S. |
Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
|
US20040077540A1
(en)
|
2002-06-28 |
2004-04-22 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
|
AU2003253883A1
(en)
|
2002-07-15 |
2004-02-02 |
The Johns Hopkins University |
Neuronal and optic nerve gene expression patterns
|
US20040038865A1
(en)
|
2002-08-01 |
2004-02-26 |
Mannkind Corporation |
Cell transport compositions and uses thereof
|
US20040043064A1
(en)
|
2002-08-29 |
2004-03-04 |
Iorio Theodore L. |
Dosage forms having reduced moisture transmission
|
US20040059282A1
(en)
|
2002-09-25 |
2004-03-25 |
Flock Stephen T. |
Microsurgical tissue treatment system
|
TW200412956A
(en)
|
2002-09-30 |
2004-08-01 |
Schering Corp |
Methods for treating disorders of calcium homeostasis
|
US20040067526A1
(en)
|
2002-10-03 |
2004-04-08 |
Cantor Thomas L. |
Methods for diagnosing and guiding treatment of bone turnover disease
|
US11284893B2
(en)
|
2019-04-02 |
2022-03-29 |
Covidien Lp |
Stapling device with articulating tool assembly
|